Tadalafil
Sold as Cialis, Ciavor, Incraflo, Tadalafil viatris, Tadalafil DYNA, Talvior, Tidalvor, Xpergo, Sentalis, Talegria, Ciatad, Actafil, Alemfil, Tadalafil biotech, Lidiax, Tadalafil cipla, Caverfil, Teldesel, Tadalafil, Tidalis, Fortad, Dysrect, Tadalafil unicorn, Tadalafil glenmark, Amotad, Taglenfil, Tadalafil unimed, Cydalatrin, Afilat, Filoryx, Teredys
(2R,8R)-2-(1,3-Benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione
Drag to rotate. Structure from PubChem CID 110635.
Background
Registration
- Applicants
- 23
- Registrations
- 67
- Schedule source
- Consolidated Schedules 06 July 2026
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Eli Lilly (S.A.) (Pty) Ltd1 of 3 cancelled | Cialis | 2,5, 5mg | 360384, 410644, 410645 | S4 | PIPIL |
| Acino Pharma (Pty) LtdCertificate held by Eli Lilly (S.A.) (Pty) Ltd | Ciavor | 5mg, 20 mg | 360385, 480657 | S4 | PIPIL |
| Smart Pharmaceuticals (Pty) Ltd | Incraflo | 20 mg | 480034 | S4 | PIPIL |
| Viatris Healthcare (Pty) Ltd | Tadalafil viatris | 5 mg | 481100 | S4 | None |
| Viatris South Africa (Pty) Ltd | Tadalafil viatris | 20 mg | 481101 | S4 | None |
| Pharma Dynamics (Pty) Ltd | Tadalafil DYNA | 5 mg, 20 mg | 490285, 490286 | S4 | None |
| Forrester Pharma (Pty) Ltd | Talvior | 5, 20 | 490785, 500661 | S4 | None |
| Aurogen South Africa (Pty) Ltd | Tidalvor, Xpergo | 5 MG, 20 MG | 490992, 490993, 490994, 490995 | S4 | None |
| Macleods Pharmaceuticals SA (Pty) Ltd | Sentalis | 5 MG, 20 MG | 491147, 491148 | S4 | None |
| Adcock ingram limited | Talegria | 5, 20 | 491196, 491197 | S4 | None |
| Ranbaxy Pharmaceutical (Pty) LtdCertificate held by Ranbaxy Pharmaceuticals (Pty) LtdCancelled | Ciatad | 5, 20 | 500010, 500011 | S4 | PIPIL |
| Actor Pharma (Pty) Ltd - Applicant | Actafil, Alemfil | 5 MG, 20 MG | 500046, 500047, 500048.046, 500049.047 | S4 | None |
| Biotech Laboratories (Pty) Ltd | Tadalafil biotech | 5, 20 | 500654, 500655 | S4 | None |
| Ranbaxy (SA) (Pty) LtdCertificate held by Ranbaxy Pharmaceuticals (Pty) Ltd | Lidiax | 5, 20 | 510014, 510015 | S4 | PIPIL |
| Cipla Medpro (Pty) LtdCertificate held by Cipla Medpro (Pty) Ltd. | Tadalafil cipla, Caverfil | 5, 5 mg/ 20 mg, 20 | 510032, 510033, 510034.032, 510035.033 | S4 | PIPIL |
| Austell Pharmaceuticals (Pty) Ltd | Teldesel, Tadalafil | 5 MG, 10 MG, 20 MG | 510279, 510280, 510281, 510282.279, 510283.28, 510284.281 | S4 | None |
| Innovata pharmaceuticals4 of 6 cancelled | Tidalis, Fortad, Dysrect | 5 MG, 20 MG | 510390, 510391, 510392.39, 510393.391, 519004, 519005 | S4 | None |
| Unicorn Pharmaceuticals (Pty) Ltd | Tadalafil unicorn | 2,5mg/5mg/20mg | 520459, 520468, 520470 | S4 | PIPIL |
| Glenmark Pharmaceuticals South Africa (Pty) Ltd | Tadalafil glenmark, Taglenfil | 5 mg, 10 mg, 20 mg | 54/7.1.5/0048.044, 540042, 540043, 540044, 540046.042, 540047.043 | S4 | None |
| Ruby Pharmaceuticals (Pty) Ltd | Amotad | 5, 20 | 540032, 540033 | S4 | PIPIL |
| Unimed Healthcare (Pty) Ltd | Tadalafil unimed | 5, 20 | 550728, 550729 | S4 | None |
| Trinity Pharma (Pty) Ltd | Cydalatrin, Afilat, Filoryx | 5, 20 | 560474, 560475, 560476.474, 560477.475, 5604780474, 560479.475 | S4 | None |
| Jubilant Pharma SA (Pty) Ltd | Teredys | 5, 20 | 570381, 570382 | S4 | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Cialis EACH TABLET CONTAINS TADALAFIL 20,0 mg | Not listed | 36038436/7.1.5/0384 | Registered | S4 | None |
| Ciavor 20 EACH TABLET CONTAINS TADALAFIL 20,0 mg | 20 mgFilm-coated tablets. | 36038536/7.1.5/0385Approved 15 March 2013 | Registered | S4 | PIPIL |
| Cialis 5 EACH TABLET CONTAINS TADALAFIL 5,0 mg | 5mgFilm coated tablets | 41064441/7.1.5/0644Approved 20 November 2025 | Registered | S4 | PIPIL |
| Cialis 2,5 EACH TABLET CONTAINS TADALAFIL 2,5 mg | 2,5 | 41064541/7.1.5/0645 | Cancelled | S4 | None |
| Incraflo 20 MG EACH TABLET CONTAINS TADALAFIL 20,0 mg | 20 mgTablet | 48003448/7.1.5/0034Approved 17 October 2023 | Registered | S4 | PIPIL |
| Ciavor 5 | 5mgFilm coated talet | 48065748/7.1.5/0657Approved 11 November 2024 | Registered | S4 | PIPIL |
| Tadalafil 5 MG viatris Each tablet contains :TADALAFIL 5,0 mg | 5 mg | 48110048/7.1.5/1100 | Registered | S4 | None |
| Tadalafil 20 MG viatris Each tablet contains :TADALAFIL 20,0 mg | 20 mg | 48110148/7.1.5/1101 | Registered | S4 | None |
| Tadalafil 5 MG DYNA EACH TABLET CONTAINS: TADALAFIL 5,0 mg | 5 mg | 49028549/7.1.5/0285 | Registered | S4 | None |
| Tadalafil 20 MG DYNA Each tablet contains TADALAFIL 20,0 mg | 20 mg | 49028649/7.1.5/0286 | Registered | S4 | None |
| Talvior 20 EACH TABLET CONTAINS :TADALAFIL 20,0 mg | 20 | 49078549/7.1.5/0785 | Registered | S4 | None |
| Tidalvor 5 MG Each tablet contains TADALAFIL 5,0 mg | 5 MG | 49099249/7.1.5/0992 | Registered | S4 | None |
| Tidalvor 20 MG Each tablet contains TADALAFIL 20,0 mg | 20 MG | 49099349/7.1.5/0993 | Registered | S4 | None |
| Xpergo 5 MG Each tablet contains TADALAFIL 5,0 mg | 5 MG | 49099449/7.1.5/0994 | Registered | S4 | None |
| Xpergo 20 MG Each tablet contains TADALAFIL 20,0 mg | 20 MG | 49099549/7.1.5/0995 | Registered | S4 | None |
| Sentalis 5 MG Each tablet contains TADALAFIL 5,0 mg | 5 MG | 49114749/7.1.5/1147 | Registered | S4 | None |
| Sentalis 20 MG Each tablet contains TADALAFIL 20,0 mg | 20 MG | 49114849/7.1.5/1148 | Registered | S4 | None |
| Talegria 5 Each tablet contains TADALAFIL 5,0 mg | 5 | 49119649/7.1.5/1196 | Registered | S4 | None |
| Talegria 20 Each tablet contains TADALAFIL 20,0 mg | 20 | 49119749/7.1.5/1197 | Registered | S4 | None |
| Ciatad 5 Each tablet contains TADALAFIL 5,0 mg | 5Film coated tablets. | 50001050/7.1.5/0010Approved 12 July 2022 | Cancelled | S4 | PIPIL |
| Ciatad 20 Each tablet contains TADALAFIL 20,0 mg | 20Film coated tablets. | 50001150/7.1.5/0011Approved 12 July 2022 | Cancelled | S4 | PIPIL |
| Actafil 5 MG Each tablet contains TADALAFIL 5,0 mg | 5 MG | 50004650/7.1.5/0046 | Registered | S4 | None |
| Actafil 20 MG Each tablet contains TADALAFIL 20,0 mg | 20 MG | 50004750/7.1.5/0047 | Registered | S4 | None |
| Alemfil 5 MG Each tablet contains TADALAFIL 5,0 mg | 5 MG | 500048.04650/7.1.5/0048.46 | Registered | S4 | None |
| Alemfil 20 MG Each tablet contains TADALAFIL 20,0 mg | 20 MG | 500049.04750/7.1.5/0049.47 | Registered | S4 | None |
| Tadalafil 5 biotech Each tablet contains TADALAFIL 5,0 mg | 5 | 50065450/7.1.5/0654 | Registered | S4 | None |
| Tadalafil 20 biotech Each tablet contains TADALAFIL 20,0 mg | 20 | 50065550/7.1.5/0655 | Registered | S4 | None |
| Talvior 5 EACH TABLET CONTAINS :TADALAFIL 5,0 mg | 5 | 50066150/7.1.5/0661 | Registered | S4 | None |
| Lidiax 5 Each tablet contains TADALAFIL 5,0 mg | 5Film coated tablets | 51001451/7.1.5/0014Approved 4 August 2023 | Registered | S4 | PIPIL |
| Lidiax 20 Each tablet contains TADALAFIL 20,0 mg | 20Film coated tablets | 51001551/7.1.5/0015Approved 4 August 2023 | Registered | S4 | PIPIL |
| Tadalafil 5 cipla Each tablet contains TADALAFIL 5,0 mg | 5Film-coated tablets | 51003251/7.1.5/0032Approved 16 January 2026 | Registered | S4 | PIPIL |
| Tadalafil 20 cipla Each tablet contains TADALAFIL 20,0 mg | 20Film-coated tablets | 51003351/7.1.5/0033Approved 16 January 2026 | Registered | S4 | PIPIL |
| Caverfil 5 Each tablet contains TADALAFIL 5,0 mg | 5 mg/ 20 mgFilm-coated tablets | 510034.03251/7.1.5/0034.032Approved 16 January 2026 | Registered | S4 | PIPIL |
| Caverfil 20 Each tablet contains TADALAFIL 20,0 mg | 5 mg/ 20 mgFilm-coated tablets | 510035.03351/7.1.5/0035.033Approved 16 January 2026 | Registered | S4 | PIPIL |
| Teldesel 5 MG tablets Each tablet contains TADALAFIL 5,0 mg | 5 MGTablets | 51027951/7.1.5/0279 | Registered | S4 | None |
| Teldesel 10 MG tablets Each tablet contains TADALAFIL 10,0 mg | 10 MGTablets | 51028051/7.1.5/0280 | Registered | S4 | None |
| Teldesel 20 MG tablets Each tablet contains TADALAFIL 20,0 mg | 20 MGTablets | 51028151/7.1.5/0281 | Registered | S4 | None |
| Tadalafil 5 MG tablets Each tablet contains TADALAFIL 5,0 mg2 | 5 MGTablets | 510282.27951/7.1.5/0282.279 | Registered | S4 | None |
| Tadalafil 10 MG tablets Each tablet contains TADALAFIL 10,0 mg | 10 MGTablets | 510283.2851/7.1.5/0283.280 | Registered | S4 | None |
| Tadalafil 20 MG tablets Each tablet contains TADALAFIL 20,0 mg | 20 MGTablets | 510284.28151/7.1.5/0284.281 | Registered | S4 | None |
| Tidalis 5 Each tablet contains TADALAFIL 5,0 mg | 5 | 51039051/7.1.5/0390 | Registered | S4 | None |
| Tidalis 20 Each tablet contains TADALAFIL 20,0 mg | 20 | 51039151/7.1.5/0391 | Registered | S4 | None |
| Fortad 5 MG Each tablet contains TADALAFIL 5,0 mg | 5 MG | 510392.3951/7.1.5/0392.390 | Cancelled | S4 | None |
| Fortad 20 MG Each tablet contains TADALAFIL 20,0 mg | 20 MG | 510393.39151/7.1.5/0393.391 | Cancelled | S4 | None |
| Dysrect 5 Each tablet contains TADALAFIL 5,0 mg | 5 | 51900451/7.1.5/9004 | Cancelled | S4 | None |
| Dysrect 20 Each tablet contains TADALAFIL 20,0 mg | 20 | 51900551/7.1.5/9005 | Cancelled | S4 | None |
| Tadalafil 5 unicorn | 2,5mg/5mg/20mgFilm-coated tablets | 52045952/7.1.5/0469Approved 7 June 2024 | Registered | S4 | PIPIL |
| Tadalafil 2,5 unicorn | 2,5mg/5mg/20mgFilm-coated tablets | 52046852/7.1.5/0468Approved 7 June 2024 | Registered | S4 | PIPIL |
| Tadalafil 20 unicorn | 2,5mg/5mg/20mgFilm-coated tablets | 52047052/7.1.5/0470Approved 7 June 2024 | Registered | S4 | PIPIL |
| Tadalafil 20 MG glenmark EACH TABLET CONTAINS TADALAFIL 20,0 mg | 20 mg | 54/7.1.5/0048.044 | Registered | S4 | None |
| Amotad 5 TADALAFIL | 5Film-coated tablets | 54003254/7.1.5/0032Approved 15 February 2024 | Registered | S4 | PIPIL |
| Amotad 20 TADALAFIL | 20Film-coated tablets | 54003354/7.1.5/0033Approved 15 February 2024 | Registered | S4 | PIPIL |
| Taglenfil 5 MG EACH TABLET CONTAINS TADALAFIL 5,0 mg | 5 mg | 54004254/7.15/0042 | Registered | S4 | None |
| Taglenfil 10 MG EACH TABLET CONTAINS TADALAFIL 10,0 mg | 10 mg | 54004354/7.1.5/0043 | Registered | S4 | None |
| Taglenfil 20 MG EACH TABLET CONTAINS TADALAFIL 20,0 mg | 20 mg | 54004454/7.1.5/0044 | Registered | S4 | None |
| Tadalafil 5 MG glenmark EACH TABLET CONTAINS TADALAFIL 5,0 mg | 5 mg | 540046.04254/7.1.5/0046.042 | Registered | S4 | None |
| Tadalafil 10 MG glenmark EACH TABLET CONTAINS TADALAFIL 10,0 mg | 10 mg | 540047.04354/7.1.5/0047.043 | Registered | S4 | None |
| Tadalafil 5 unimed EACH TABLET CONTAINS TADALAFIL 5,0 mg | 5 | 55072855/7.1.5/0728 | Registered | S4 | None |
| Tadalafil 20 unimed EACH TABLET CONTAINS TADALAFIL 20,0 mg | 20 | 55072955/7.1.5/0729 | Registered | S4 | None |
| Cydalatrin 5 EACH TABLET CONTAINS TADALAFIL 5,0 mg | 5 | 56047456/7.1.5/0474 | Registered | S4 | None |
| Cydalatrin 20 EACH TABLET CONTAINS TADALAFIL 20,0 mg | 20 | 56047556/7.1.5/0475 | Registered | S4 | None |
| Afilat 5 EACH TABLET CONTAINS TADALAFIL 5,0 mg | 5 | 560476.47456/7.1.5/0476.474 | Registered | S4 | None |
| Afilat 20 EACH TABLET CONTAINS TADALAFIL 20,0 mg | 20 | 560477.47556/7.1.5/0477.475 | Registered | S4 | None |
| Filoryx 5 EACH TABLET CONTAINS TADALAFIL 5,0 mg | 5 | 560478047456/7.1.5/0478.474 | Registered | S4 | None |
| Filoryx 20 EACH TABLET CONTAINS TADALAFIL 20,0 mg | 20 | 560479.47556/7.1.5/0479.475 | Registered | S4 | None |
| Teredys 5 Each Tablet contains: Tadalafil 5,0 mg | 5 | 57038157/7.1.5/0381 | Registered | S4 | None |
| Teredys 20 Each Tablet contains: Tadalafil 20,0 mg | 20 | 57038257/7.1.5/0382 | Registered | S4 | None |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Tadalafil
S4: Tadalafil
Consolidated Schedules 06 July 2026, line 8086
Pharmacological class: Vasodilators - peripheral. (class 7.1.5)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
Schedule Verification
Ciavor 20, Acino Pharma (Pty) Ltd is scheduled S4 in its official SAHPRA documents, read with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.